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Background
Traditionally, CD8+ T cells have been defined as being
immunogenic; however, they have also been shown to
demonstrate a tolerogenic phenotype. One area less
studied, regarding the tolerogenic phenotype of CD8+ T
cells, is their role in cancer. What has been described is
that their suppressive phenotype is suggested to be
developed in the tumor microenvironment and can be
correlated with the CD8+ T cells becoming CD27/28-.
What is unclear is the general mechanism that may trig-
ger the tolerogenic development in CD8+ T cells. Via
multiple cancer cell lines, this research identified that
tumor derived (TD) exosomes will cause the development
of the tolerogenic phenotype in CD3+CD8+ T cells.
Methods
Conditioned growth media from tumor cell lines were
processed by an exosome precipitation solution to purify
exosomes. Confirmation of exosome isolation was based
upon the identification of 10 commonly found exosomal
proteins from the purification. Human CD3+CD8+ T cells
were incubated with TD exosomes, tumor conditioned
growth medium with and without exosomes, and exosome-
free complete RPMI. Following this incubation, the CD3
+CD8+ T cells were analyzed for CD27/28 loss by flow
cytometry and suppression analysis (BrdU incorporation
assay) to examine for the tolerogenic T cell phenotype.
Results
The exosome-free complete RPMI control group and the
tumor cell line conditioned growth medium without exo-
some group, showed CD3+CD8+ T cell’s CD27/28 loss
to be at most 12% of the population. In contrast, CD27/
28 loss, when CD3+CD8+ T cells were incubated with
tumor conditioned growth medium and TD exosomes,
were at the most 50% of the population. Congruent loss
of CD27/28 expression was associated with an increased
ability to suppress responder T cell proliferation, indicat-
ing immunosuppression.
Conclusions
This research has identified TD exosomes from multiple
cancer cell lines as a factor causing the CD3+CD8+ T
cell tolerogenic phenotype. Furthermore, the lack of
cell-to-cell contact needed between CD3+CD8+ T cells
and the cancer cell lines to trigger this tolerogenic phe-
notype implies that CD3+CD8+ T cell exposure to the
tumor microenvironment may not be required for these
cells to become suppressor cells. Current research is
involved in the purification of the factor(s) from the TD
exosomes that may be causing this effect. Upon further
identification of this factor(s) it could be used to better
understand the etiology of the dysfunction in immuno-
surveillance due to immunosubversion.
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